Posted by Jamal Spelling on January 17, 2008, at 12:38:03
In reply to Bias in reporting antidepressant effectiveness, posted by zazenducke on January 17, 2008, at 12:09:56
> Dr. Thomas P. Laughren, director of the division of psychiatry products at the F.D.A., said the agency had long been aware that favorable studies of drugs were more likely to be published in journals.
>
> Its a problem weve been struggling with for years, he said in an interview. I have no problem with full access to all trial data; the question for us is how do you fit it all on a package insert, the condensed prescribing information that accompanies many drugs.If you have no problem with full access to trial data, Dr Laughren, then why do researchers have to invoke the Freedom of Information Act in order to access this data?
poster:Jamal Spelling
thread:807228
URL: http://www.dr-bob.org/babble/20080114/msgs/807242.html